Market Overview

Amazon Could Partner With UnitedHealth For Pharmacy Unit By Thanksgiving

Share:
Amazon Could Partner With UnitedHealth For Pharmacy Unit By Thanksgiving
Related UNH
After Basking In The Glow Of Netflix Results And Tuesday Rally, Pressure Seems Possible
Bank Earnings To The Rescue? Market Seeing Some Green After Strong Results
Dow Jones Futures: Why This Stock Market Correction Is More Dangerous Than A Bear Market (Investor's Business Daily)
Related AMZN
PayPal Sneezes, eBay Catches A Cold: RBC Downgrades Online Auction Platform On Negative Data
Wall Street Starts The Day In Risk-off Mood As Global Sentiment Weakens
JPMorgan "a bit more cautious" ahead of Amazon's earnings (Seeking Alpha)

Last week, Leerink analyst David Larsen said that it’s only a matter of time before Amazon.com, Inc. (NASDAQ: AMZN) takes the plunge into the pharmacy business and that Amazon could be selling prescription drugs within two years’ time. On Monday, Bernstein analyst Lance Wilkes said Amazon investors may not need to wait two years.

According to Wilkes, Amazon will likely make its pharmacy intentions official and public before Thanksgiving. Rather than build its own pharmacy benefit manager business from scratch, Wilkes said he expects Amazon to go the Whole Foods route and either buy or partner with an existing PBM.

“Over the past five months we have stated that we think Amazon will enter the retail pharmacy industry, we think they will most likely partner/buy a PBM to enable their entry, and we think they will address the major challenges which have faced online (mail) pharmacy, which are user experience, convenience and price,” Wilkes wrote.

Bernstein sees a partnership with UnitedHealth Group Inc (NYSE: UNH)’s OptumRx as the path that makes the most sense for Amazon. However, Amazon could also still choose to buy a mail-order pharmacy business or take over a mid-sized independent PBM. Wilkes specifically noted that he does not see Express Scripts Holding Company (NASDAQ: ESRX) as a likely buyout target for Amazon.

Bernstein is expecting Amazon to have its pharmacy business up and running in 2019 and in time for 2020 benefit plans. Not only would Amazon’s presence threaten the market share of all the major drug retailers and PBM’s, including Walgreens Boots Alliance Inc (NASDAQ: WBA) and CVS Health Corp (NYSE: CVS), Wilkes said it could pressure margins across the board, including those of a potential partner.

Bernstein has an Outperform rating and $210 price target for UnitedHealth.

Related Link: Analyst: Amazon's Entry Into Pharmacy Is All But Certain At This Point

Latest Ratings for UNH

DateFirmActionFromTo
Oct 2018Raymond JamesMaintainsStrong BuyStrong Buy
Oct 2018Bank of AmericaMaintainsBuyBuy
Oct 2018BarclaysMaintainsOverweightOverweight

View More Analyst Ratings for UNH
View the Latest Analyst Ratings

Posted-In: Analyst Color Biotech Long Ideas News Health Care Rumors Reiteration M&A Best of Benzinga

 

Related Articles (AMZN + CVS)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TEAMKeyBancUpgrades89.0
VIABImperial CapitalUpgrades29.0
AMDBarclaysUpgrades25.0
CDNSJP MorganUpgrades51.0
EBAYRBC CapitalDowngrades0.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Stocks Going Ex Dividend The Second Week Of October

Mid-Day Market Update: K2M Group Drops On Weak Sales Outlook; Sphere 3D Shares Climb